VIVID TECHNOLOGIES INC
Medtech · Private
In situ assay for detecting and quantifying topoisomerase 2-mediated DNA breaks in tissue sections and cells
- Grants
- $749K
- 4 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201720182019202020212022
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · In situ assay for RNA decapping in tumors | $149,051 | |
| Federal grant | Department of Health and Human Services · Phase I · In situ assay for RNA decapping in tumors | $149,051 | |
| Federal grant | Department of Health and Human Services · Phase I · New specific and rapid assay for in situ apoptosis labeling for cancer studies | $214,214 | |
| Federal grant | Department of Health and Human Services · Phase I · In situ assay for topoisomerase 2-mediated DNA damage | $236,684 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1583 | Peritas AI Inc. | — | $6.4M |
| 1584 | NEOVATIVE, INC. | — | — |
| 1585 | Revive Biotechnology Inc. | — | — |
| 1586 | VIVID TECHNOLOGIES INC | — | — |
| 1587 | OMNECOIL INSTRUMENTS, INC. | — | — |
| 1588 | Pontosense Inc. | — | $4.4M |
| 1589 | NOVIS PRODUCTS, LLC | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.